UBS Group’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
459,963
+171,870
+60% +$651K ﹤0.01% 5121
2025
Q4
$850K Sell
288,093
-495,352
-63% -$1.36M ﹤0.01% 5711
2025
Q3
$1.9M Buy
783,445
+19,956
+3% +$64K ﹤0.01% 5005
2025
Q2
$2.5M Buy
763,489
+324,722
+74% +$1.18M ﹤0.01% 4579
2025
Q1
$1.69M Sell
438,767
-1,032,664
-70% -$4.29M ﹤0.01% 4850
2024
Q4
$5.68M Buy
1,471,431
+1,471,430
+147,143,000% +$8.12M ﹤0.01% 3688
2024
Q3
$7 Buy
+1
New +$7 ﹤0.01% 9374
2024
Q2
Sell
-1
Closed -$11 9510
2024
Q1
$11 Sell
1
-203
-100% -$1.66K ﹤0.01% 9081
2023
Q4
$1.8K Buy
+204
New +$1.56K ﹤0.01% 8221
2023
Q2
Sell
-8,192
Closed -$63.1K 8904
2023
Q1
$63.1K Buy
+8,192
New +$66.5K ﹤0.01% 6272
2022
Q4
Sell
-9,693
Closed -$94K 10722
2022
Q3
$94K Buy
9,693
+9,136
+1,640% +$114K ﹤0.01% 5757
2022
Q2
$8K Sell
557
-300
-35% -$5.14K ﹤0.01% 8280
2022
Q1
$16K Hold
857
﹤0.01% 7727
2021
Q4
$18K Sell
857
-3,159
-79% -$62.6K ﹤0.01% 7960
2021
Q3
$88K Buy
4,016
+2,154
+116% +$49.8K ﹤0.01% 5910
2021
Q2
$44K Sell
1,862
-2,792
-60% -$55.7K ﹤0.01% 6544
2021
Q1
$66K Buy
4,654
+3,225
+226% +$35.4K ﹤0.01% 6272
2020
Q4
$13K Sell
1,429
-224,260
-99% -$1.91M ﹤0.01% 7263
2020
Q3
$1.69M Buy
225,689
+221,834
+5,754% +$1.91M ﹤0.01% 3214
2020
Q2
$33K Buy
3,855
+2,360
+158% +$20.3K ﹤0.01% 6201
2020
Q1
$10K Sell
1,495
-3,004
-67% -$38.3K ﹤0.01% 6916
2019
Q4
$67K Buy
+4,499
New +$62.9K ﹤0.01% 6199
2019
Q2
Sell
-9,513
Closed -$245K 7847
2019
Q1
$245K Sell
9,513
-3,065
-24% -$84.8K ﹤0.01% 4491
2018
Q4
$308K Buy
12,578
+6
+0% +$163 ﹤0.01% 4610
2018
Q3
$363K Buy
12,572
+5,662
+82% +$161K ﹤0.01% 4635
2018
Q2
$180K Sell
6,910
-15,962
-70% -$412K ﹤0.01% 5027
2018
Q1
$663K Sell
22,872
-20,721
-48% -$603K ﹤0.01% 4011
2017
Q4
$1.15M Buy
43,593
+37,941
+671% +$1.08M ﹤0.01% 3673
2017
Q3
$151K Buy
5,652
+1,670
+42% +$41K ﹤0.01% 5041
2017
Q2
$82K Sell
3,982
-2,028
-34% -$41.8K ﹤0.01% 5297
2017
Q1
$122K Buy
6,010
+297
+5% +$6.25K ﹤0.01% 4957
2016
Q4
$121K Buy
+5,713
New +$101K ﹤0.01% 5158
2016
Q2
Sell
-574
Closed -$8K 7714
2016
Q1
$8K Buy
+574
New +$7.33K ﹤0.01% 6773
2015
Q4
Sell
-34,220
Closed -$288K 8332
2015
Q3
$288K Sell
34,220
-20,674
-38% -$160K ﹤0.01% 4349
2015
Q2
$475K Buy
54,894
+9,275
+20% +$79.2K ﹤0.01% 4171
2015
Q1
$317K Buy
45,619
+42,582
+1,402% +$389K ﹤0.01% 4511
2014
Q4
$39K Buy
+3,037
New +$42.5K ﹤0.01% 6791

Other funds holding BAK

UBS Group's BAK Position: Q1 2026 in Review

UBS Group increased its Braskem (BAK) stake by 60% in Q1 2026, buying an estimated $651K and bringing the position to 459,963 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #5121.

UBS Group first reported a position in BAK in Q4 2014 and has held it in 37 quarters since. The position peaked at $5.68M in Q4 2024. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • UBS Group held 459,963 shares of Braskem worth $1.68M as of Q1 2026.
  • UBS Group bought 171,870 Braskem shares in Q1 2026, an estimated $651K.
  • Braskem made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5121 holding.
  • UBS Group first reported a position in Braskem in Q4 2014 and has held it in 37 quarters since.
  • UBS Group's Braskem position peaked at $5.68M in Q4 2024.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.